PM
Parametrica Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,300
| Closed | -$1.37M | – | 94 |
|
|
2024
Q3 | $1.37M | Buy |
+1,300
| New | +$1.37M | 1.63% | 17 |
|
|
2024
Q2 | – | Sell |
-1,600
| Closed | -$1.54M | – | 29 |
|
|
2024
Q1 | $1.54M | Sell |
1,600
-13
| -0.8% | -$12.5K | 2.22% | 14 |
|
|
2023
Q4 | $1.42M | Sell |
1,613
-2,330
| -59% | -$2.05M | 2.33% | 14 |
|
|
2023
Q3 | $3.24M | Sell |
3,943
-41
| -1% | -$33.7K | 5.46% | 6 |
|
|
2023
Q2 | $2.86M | Buy |
3,984
+861
| +28% | +$619K | 5.51% | 6 |
|
|
2023
Q1 | $2.57M | Buy |
+3,123
| New | +$2.57M | 4.63% | 8 |
|
|
2021
Q1 | – | Sell |
-1,773
| Closed | -$857K | – | 220 |
|
|
2020
Q4 | $857K | Buy |
+1,773
| New | +$857K | 0.53% | 40 |
|
|
2016
Q2 | – | Sell |
-1,120
| Closed | -$404K | – | 231 |
|
|
2016
Q1 | $404K | Buy |
+1,120
| New | +$404K | 1.45% | 13 |
|